Growth Metrics

Nuwellis (NUWE) Operating Leases (2019 - 2025)

Nuwellis posted quarterly Operating Leases of $67000.0 for Q4 2025, down 78.18% year-on-year from $307000.0 in Q4 2024, and down 47.66% on a QoQ basis from $128000.0 in Q3 2025.

Nuwellis (NUWE) has 7 years of Operating Leases data on file, last reported at $67000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Operating Leases fell 78.18% year-over-year to $67000.0; the trailing twelve-month figure through Dec 2025 stood at $67000.0 (down 78.18% YoY), and the FY2025 full-year result was $67000.0, down 78.18% from the prior year.
  • Operating Leases for Q4 2025 stood at $67000.0, down from $128000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $956000.0 in Q4 2021 and bottomed at $67000.0 in Q4 2025.
  • The 5-year median for Operating Leases is $544000.0 (2023), against an average of $530941.2.
  • The widest annual swing landed in 2021, when Operating Leases surged 1638.18%; it then slumped 78.18% in 2025.
  • A 5-year view of Operating Leases shows it stood at $956000.0 in 2021, then retreated by 20.5% to $760000.0 in 2022, then retreated by 28.42% to $544000.0 in 2023, then tumbled by 43.57% to $307000.0 in 2024, then plunged by 78.18% to $67000.0 in 2025.
  • The last three Operating Leases figures came in at $67000.0 (Q4 2025), $128000.0 (Q3 2025), and $189000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Nuwellis 1.45 Mn -630,292.49 1.68 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 67,000.00
Sep 30, 2025 128,000.00
Jun 30, 2025 189,000.00
Mar 31, 2025 249,000.00
Dec 31, 2024 307,000.00
Sep 30, 2024 368,000.00
Jun 30, 2024 428,000.00
Mar 31, 2024 488,000.00
Dec 31, 2023 544,000.00
Sep 30, 2023 601,000.00
Jun 30, 2023 654,000.00
Mar 31, 2023 708,000.00
Dec 31, 2022 760,000.00
Sep 30, 2022 810,000.00
Jun 30, 2022 860,000.00
Mar 31, 2022 909,000.00
Dec 31, 2021 956,000.00
Dec 31, 2020 55,000.00
Sep 30, 2020 108,000.00
Jun 30, 2020 160,000.00
Mar 31, 2020 212,000.00
Dec 31, 2019 261,000.00
Sep 30, 2019 309,000.00
Jun 30, 2019 357,000.00
Mar 31, 2019 403,000.00